Shiraz E-Medical Journal

Published by: Neoscriber Demo Publisher

Prevalence of BRAFV600E Mutation and Human Parvovirus B19 Infection in Thyroid Cancer

Mohammadreza Ghasemi 1 , Abbas Behzad Behbahani 1 , Ali Farhadi 1 , * , Tahereh Pakdel 1 and Mohammad Javad Ashraf 2
Authors Information
1 Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
2 Department of Pathology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
Article information
  • Shiraz E-Medical Journal: 20 (6); e84207
  • Published Online: May 8, 2019
  • Article Type: Research Article
  • Received: September 12, 2018
  • Revised: November 17, 2018
  • Accepted: November 19, 2018
  • DOI: 10.5812/semj.84207

To Cite: Ghasemi M, Behzad Behbahani A , Farhadi A, Pakdel T, Ashraf M J . Prevalence of BRAFV600E Mutation and Human Parvovirus B19 Infection in Thyroid Cancer, Shiraz E-Med J. Online ahead of Print ; 20(6):e84207. doi: 10.5812/semj.84207.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer. 2013;13(3):184-99. doi: 10.1038/nrc3431. [PubMed: 23429735]. [PubMed Central: PMC3791171].
  • 2. Baloch ZW, LiVolsi VA. Special types of thyroid carcinoma. Histopathology. 2018;72(1):40-52. doi: 10.1111/his.13348. [PubMed: 29239042].
  • 3. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883-99. doi: 10.1016/j.cell.2010.01.025. [PubMed: 20303878]. [PubMed Central: PMC2866629].
  • 4. Xing M. Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer. Thyroid. 2010;20(7):697-706. doi: 10.1089/thy.2010.1646. [PubMed: 20578891]. [PubMed Central: PMC2935335].
  • 5. Kebebew E, Weng J, Bauer J, Ranvier G, Clark OH, Duh QY, et al. The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg. 2007;246(3):466-70. discussion 470-1. doi: 10.1097/SLA.0b013e318148563d. [PubMed: 17717450]. [PubMed Central: PMC1959359].
  • 6. Okada F. Inflammation-related carcinogenesis: Current findings in epidemiological trends, causes and mechanisms. Yonago Acta Med. 2014;57(2):65-72. [PubMed: 25324587]. [PubMed Central: PMC4198572].
  • 7. Morales-Sanchez A, Fuentes-Panana EM. Human viruses and cancer. Viruses. 2014;6(10):4047-79. doi: 10.3390/v6104047. [PubMed: 25341666]. [PubMed Central: PMC4213577].
  • 8. Doorbar J, Egawa N, Griffin H, Kranjec C, Murakami I. Human papillomavirus molecular biology and disease association. Rev Med Virol. 2015;25 Suppl 1:2-23. doi: 10.1002/rmv.1822. [PubMed: 25752814]. [PubMed Central: PMC5024016].
  • 9. Etemadi A, Mostafaei S, Yari K, Ghasemi A, Minaei Chenar H, Moghoofei M. Detection and a possible link between parvovirus B19 and thyroid cancer. Tumour Biol. 2017;39(6):1.0104283177036E+15. doi: 10.1177/1010428317703634. [PubMed: 28618936].
  • 10. Adamson-Small LA, Ignatovich IV, Laemmerhirt MG, Hobbs JA. Persistent parvovirus B19 infection in non-erythroid tissues: Possible role in the inflammatory and disease process. Virus Res. 2014;190:8-16. doi: 10.1016/j.virusres.2014.06.017. [PubMed: 24998884].
  • 11. Hsu TC, Tzang BS, Huang CN, Lee YJ, Liu GY, Chen MC, et al. Increased expression and secretion of interleukin-6 in human parvovirus B19 non-structural protein (NS1) transfected COS-7 epithelial cells. Clin Exp Immunol. 2006;144(1):152-7. doi: 10.1111/j.1365-2249.2006.03023.x. [PubMed: 16542377]. [PubMed Central: PMC1809635].
  • 12. Wang J, Zhang W, Liu H, Wang D, Wang W, Li Y, et al. Parvovirus B19 infection associated with Hashimoto's thyroiditis in adults. J Infect. 2010;60(5):360-70. doi: 10.1016/j.jinf.2010.02.006. [PubMed: 20153771].
  • 13. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985;230(4732):1350-4. [PubMed: 2999980].
  • 14. Giannini R, Ugolini C, Lupi C, Proietti A, Elisei R, Salvatore G, et al. The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma. J Clin Endocrinol Metab. 2007;92(9):3511-6. doi: 10.1210/jc.2007-0594. [PubMed: 17535994].
  • 15. Zur Hausen H. Viruses in human cancers. Curr Sci. 2001;81:523-7.
  • 16. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030-44. doi: 10.1002/ijc.21731. [PubMed: 16404738].
  • 17. Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol Oncol. 2015;136(2):178-82. doi: 10.1016/j.ygyno.2014.12.022. [PubMed: 25579107].
  • 18. Bangham CRM, Matsuoka M. Human T-cell leukaemia virus type 1: Parasitism and pathogenesis. Philos Trans R Soc Lond B Biol Sci. 2017;372(1732). doi: 10.1098/rstb.2016.0272. [PubMed: 28893939]. [PubMed Central: PMC5597739].
  • 19. Lee MH, Yang HI, Yuan Y, L'Italien G, Chen CJ. Epidemiology and natural history of hepatitis C virus infection. World J Gastroenterol. 2014;20(28):9270-80. doi: 10.3748/wjg.v20.i28.9270. [PubMed: 25071320]. [PubMed Central: PMC4110557].
  • 20. Schulz TF, Cesarman E. Kaposi Sarcoma-associated Herpesvirus: Mechanisms of oncogenesis. Curr Opin Virol. 2015;14:116-28. doi: 10.1016/j.coviro.2015.08.016. [PubMed: 26431609].
  • 21. Lipson EJ, Vincent JG, Loyo M, Kagohara LT, Luber BS, Wang H, et al. PD-L1 expression in the Merkel cell carcinoma microenvironment: Association with inflammation, Merkel cell polyomavirus and overall survival. Cancer Immunol Res. 2013;1(1):54-63. doi: 10.1158/2326-6066.CIR-13-0034. [PubMed: 24416729]. [PubMed Central: PMC3885978].
  • 22. Kerr JR, Barah F, Cunniffe VS, Smith J, Vallely PJ, Will AM, et al. Association of acute parvovirus B19 infection with new onset of acute lymphoblastic and myeloblastic leukaemia. J Clin Pathol. 2003;56(11):873-5. doi: 10.1136/jcp.56.11.873. [PubMed: 14600138]. [PubMed Central: PMC1770100].
  • 23. Ignatovich IV, Hobbs JA. Human parvovirus B19 infection leads to downregulation of thyroid, estrogen, and retinoid hormone receptor expression. Virology. 2013;446(1-2):173-9. doi: 10.1016/j.virol.2013.06.022. [PubMed: 24074579].
  • 24. Ranjbari N, Almasi S, Mohammadi-Asl J, Rahim F. BRAF mutations in Iranian patients with papillary thyroid carcinoma. Asian Pac J Cancer Prev. 2013;14(4):2521-3. [PubMed: 23725167].
  • 25. Wang JH, Zhang WP, Liu HX, Wang D, Li YF, Wang WQ, et al. Detection of human parvovirus B19 in papillary thyroid carcinoma. Br J Cancer. 2008;98(3):611-8. doi: 10.1038/sj.bjc.6604196. [PubMed: 18212749]. [PubMed Central: PMC2243166].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments